Content about Anti-diabetic drugs

November 17, 2010
Byetta may cut cardiovascular risk for diabetes patients

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 15, 2010
JDRF, Amylin support clinical proof-of-concept study

A leading charitable funder of and advocate for Type 1 diabetes research and a drug...

November 7, 2010
FDA approves Kombiglyze XR

The Food and Drug Administration approved the first and only once-a-day metformin extended-release plus dipeptidyl...

November 7, 2010
Study finds GLP-1 analogues may improve blood-glucose levels, BMI

A new study conducted by University of Toronto researchers found that GLP-1 analogues not only...

November 2, 2010
Biodel receives complete response letter for Linjeta

The Food and Drug Administration has turned down an application for an insulin product made...

November 2, 2010
Lilly CEO: 'New approaches' must be found to combat diabetes

The CEO of drug maker Eli Lilly has called for a “wave of invention” to...

October 31, 2010
Stater Bros. to offer free diabetes drugs at select locations

Supermarket chain Stater Bros. will mark National Diabetes Awareness Month by offering free diabetes drugs...

October 27, 2010
Cigna, Merck Helps band together to stop diabetes

An insurance company and a patient assistance program have joined forces to improve medication adherence...

October 27, 2010
Decision Resources: More patients switch to Onglyza from Merck's Type 2 diabetes drugs

Many Type 2 diabetes patients who use the drug Onglyza (saxagliptin) switched to that drug...

October 24, 2010
Reports: Lilly may acquire other companies following Bydureon setback

Speculation has emerged that Eli Lilly may seek to acquire several other companies in light...

October 19, 2010
FDA declines to approve Bydureon

The Food and Drug Administration declined to approve a long-anticipated diabetes drug made by Eli...

October 17, 2010
Pfizer inks deal with Biocon

Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute...

September 30, 2010
UltiMed names VP diabetes care

UltiMed, a company that makes insulin-delivery devices, has named a new executive....

September 23, 2010
AstraZeneca-Bristol drug just as effective as generic on market, trial results show

An investigational diabetes drug works as well as a generic already on the market, according...

September 22, 2010
FDA to allow GSK’s Avandia, with restrictions

The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes...

September 19, 2010
Sanofi-Aventis: Lantus provides further blood-sugar reduction for patients with Type 2 diabetes

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

September 19, 2010
Sanofi-Aventis: Lixisenatide aids blood-glucose control for Type 2 diabetics

An investigational treatment made by French drug maker Sanofi-Aventis showed “significant” improvement in blood-glucose control...

August 31, 2010
Biodel's VIAject gets name change

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 29, 2010
Novo Nordisk launches NovoDose

Novo Nordisk has launched a mobile dosing app for healthcare professionals that prescribe the drug...

August 15, 2010
JDRF announces insulin initiative for artificial pancreas program

The Juvenile Diabetes Research Foundation has expanded its artifical pancreas program with an initiative that...

July 20, 2010
Tongli drugs listed as 'needed medicines' in China

A Chinese drug maker has had three of its drugs included in the country’s list...

June 27, 2010
Study data shows Victoza works better than competitor

A recently approved drug for Type 2 diabetes made by Novo Nordisk worked better than...

June 24, 2010
Metabolex, Sanofi-Aventis announce new partnership

French drug maker Sanofi-Aventis has made a deal with U.S. drug maker Metabolex to license...

June 21, 2010
Generex to exhibit at ADA meeting

Generex Biotechnology Corp. will be among the companies exhibiting at an upcoming American Diabetes Association...

June 20, 2010
Roche implements risk-mitigation plan for taspoglutide

Swiss drug maker Roche has started a risk-mitigation plan in the late-stage clinical trial of...

© 2013 Drug Store News. All Rights Reserved.